One Wealth Advisors’s ESSA Pharma EPIX Stock Holding History

One Wealth Advisors’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,333	Closed	-$21K	–	324
2022 Q4	$21K	Buy	+8,333	New	+$23.9K	﹤0.01%	520
2021 Q3	–	Sell	-8,333	Closed	-$238K	–	222
2021 Q2	$238K	Hold	8,333	–	–	0.08%	150
2021 Q1	$242K	Buy	+8,333	New	+$194K	0.09%	128

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

One Wealth Advisors's EPIX Position: Q1 2023 in Review

One Wealth Advisors sold out of ESSA Pharma (EPIX) in Q1 2023, closing a stake of 8,333 shares — an estimated $21K sold.

One Wealth Advisors first reported a position in EPIX in Q1 2021 and held it in 3 quarters. The position peaked at $242K in Q1 2021. 37 funds tracked by Wall St. Rank hold EPIX as of Q1 2023.

One Wealth Advisors reported no remaining ESSA Pharma position as of Q1 2023 after selling out during the quarter.
One Wealth Advisors sold 8,333 ESSA Pharma shares in Q1 2023, an estimated $21K.
One Wealth Advisors first reported a position in ESSA Pharma in Q1 2021 and held it in 3 quarters.
One Wealth Advisors's ESSA Pharma position peaked at $242K in Q1 2021.
37 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2023.

Based on One Wealth Advisors's 13F filing for Q1 2023, filed 15 May 2023.